Evaluation of presynaptic histamine receptors in the canine renal vascular bed.
Histamine has been shown to increase renal blood flow via H1- and H2-receptors. Furthermore, H2-receptors have been demonstrated to attenuate stimulation-induced release of norepinephrine. The present studies examined whether histamine has a presynaptic effect on sympathetic nerves in the canine renal vascular bed. Renal blood flow was measured in anesthetized dogs, and vasoconstrictor responses to renal nerve stimulation and i.a. injections of norepinephrine were compared before and during i.a. infusions of histamine. Histamine increased renal blood flow and decreased stimulation-induced vasoconstriction to a greater degree than norepinephrine responses. 2-(2-pyridyl)ethylamine, an H1-agonist, did not produce consistent effects. Dimaprit, an H2-agonist, produced responses similar to histamine but to a lesser extent. The H1-antagonist tripelennamine and the H2-antagonist cimetidine each minimally antagonized the effect of histamine on nerve stimulation. When both blocking agents were infused together, maximum antagonism of histamine occurred. Thus, it appears that histamine will produce a neuroinhibitory effect in the canine renal vascular bed and this effect appears to be mediated by both H1- and H2-receptors because both receptor antagonists are necessary to block this effect.
D000818:Animals; D001783:Blood Flow Velocity; D002927:Cimetidine / Q000008:administration & dosage; D004285:Dogs; D005260:Female; D006632:Histamine / Q000008:administration & dosage* / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000008:administration & dosage; D006635:Histamine H2 Antagonists / Q000008:administration & dosage; D007668:Kidney / Q000098:blood supply* / Q000294:innervation / Q000378:metabolism; D008297:Male; D009638:Norepinephrine / Q000008:administration & dosage; D011969:Receptors, Histamine H1 / Q000032:analysis / Q000187:drug effects; D011970:Receptors, Histamine H2 / Q000032:analysis / Q000187:drug effects; D017981:Receptors, Neurotransmitter / Q000032:analysis* / Q000187:drug effects; D013564:Sympathetic Nervous System / Q000187:drug effects* / Q000378:metabolism; D014309:Tripelennamine / Q000008:administration & dosage; D014662:Vasoconstrictor Agents / Q000008:administration & dosage
D006634:Histamine H1 Antagonists; D006635:Histamine H2 Antagonists; D011969:Receptors, Histamine H1; D011970:Receptors, Histamine H2; D017981:Receptors, Neurotransmitter; D014662:Vasoconstrictor Agents; D014309:Tripelennamine; D002927:Cimetidine; D006632:Histamine; D009638:Norepinephrine